A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule…

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, January 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 704 followers.

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albacona... http://t.co/rhyhmQTy

Reply Repost Favourite

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albacona... http://t.co/g1NXzvy5

Reply Repost Favourite